News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,586 Results
Type
Article (14698)
Company Profile (282)
Press Release (256606)
Multimedia
Podcasts (59)
Webinars (7)
Section
Business (80112)
Career Advice (153)
Deals (13358)
Drug Delivery (42)
Drug Development (51209)
Employer Resources (31)
FDA (5862)
Job Trends (5232)
News (145955)
Policy (10276)
Tag
Academia (920)
Accelerated approval (3)
Adcomms (26)
Allergies (52)
Alliances (21855)
ALS (71)
Alzheimer's disease (901)
Antibody-drug conjugate (ADC) (157)
Approvals (5872)
Artificial intelligence (139)
Autoimmune disease (19)
Automation (5)
Bankruptcy (106)
Best Places to Work (4653)
BIOSECURE Act (7)
Biosimilars (45)
Biotechnology (232)
Bladder cancer (61)
Brain cancer (21)
Breast cancer (197)
Cancer (1650)
Cardiovascular disease (123)
Career advice (134)
Career pathing (2)
CAR-T (128)
Cell therapy (348)
Cervical cancer (13)
Clinical research (41803)
Collaboration (574)
Compensation (282)
Complete response letters (15)
COVID-19 (1063)
CRISPR (44)
C-suite (174)
Cystic fibrosis (78)
Data (1666)
Denatured (11)
Depression (32)
Diabetes (149)
Diagnostics (1314)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (32)
Drug shortages (4)
Duchenne muscular dystrophy (92)
Earnings (30378)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (49295)
Executive appointments (478)
FDA (6653)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (521)
Gene editing (102)
Generative AI (10)
Gene therapy (268)
GLP-1 (381)
Government (1117)
Grass and pollen (2)
Guidances (71)
Healthcare (6767)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (101)
Indications (20)
Infectious disease (1131)
Inflammatory bowel disease (120)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (69)
Interviews (18)
IPO (7342)
IRA (13)
Job creations (872)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (221)
Leadership (3)
Legal (1406)
Liver cancer (35)
Lung cancer (241)
Lymphoma (112)
Machine learning (5)
Management (7)
Manufacturing (160)
MASH (63)
Medical device (2618)
Medtech (2619)
Mergers & acquisitions (6360)
Metabolic disorders (418)
Multiple sclerosis (53)
NASH (14)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1330)
NextGen: Class of 2025 (2041)
Non-profit (861)
Now hiring (22)
Obesity (198)
Opinion (107)
Ovarian cancer (70)
Pain (46)
Pancreatic cancer (61)
Parkinson's disease (125)
Partnered (8)
Patents (143)
Patient recruitment (87)
Peanut (35)
People (25801)
Pharmaceutical (50)
Pharmacy benefit managers (5)
Phase I (14741)
Phase II (19396)
Phase III (12367)
Pipeline (969)
Policy (53)
Postmarket research (861)
Preclinical (6212)
Press Release (30)
Prostate cancer (68)
Psychedelics (35)
Radiopharmaceuticals (218)
Rare diseases (302)
Real estate (1445)
Recruiting (12)
Regulatory (8916)
Reports (16)
Research institute (946)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (101)
Series B (71)
Service/supplier (1)
Sickle cell disease (42)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1980)
State (1)
Stomach cancer (10)
Supply chain (24)
Tariffs (13)
The Weekly (47)
Vaccines (232)
Venture capitalists (32)
Weight loss (113)
Women's health (15)
Worklife (2)
Date
Today (71)
Last 7 days (624)
Last 30 days (1923)
Last 365 days (19700)
2025 (7237)
2024 (20940)
2023 (22703)
2022 (27106)
2021 (28008)
2020 (23553)
2019 (16439)
2018 (11903)
2017 (13868)
2016 (11937)
2015 (14469)
2014 (10475)
2013 (7562)
2012 (7609)
2011 (7669)
2010 (7470)
Location
Africa (155)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17726)
Australia (2957)
California (4118)
Canada (1180)
China (401)
Colorado (153)
Connecticut (160)
Delaware (119)
Europe (37766)
Florida (505)
Georgia (124)
Idaho (16)
Illinois (240)
India (11)
Indiana (94)
Iowa (2)
Japan (102)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (499)
Massachusetts (3282)
Michigan (75)
Minnesota (152)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (18)
New Hampshire (14)
New Jersey (1070)
New Mexico (12)
New York (1120)
North Carolina (574)
North Dakota (5)
Northern California (1850)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (775)
Puerto Rico (6)
Rhode Island (19)
South America (215)
South Carolina (5)
Southern California (1570)
Tennessee (25)
Texas (478)
United States (14139)
Utah (56)
Virginia (84)
Washington D.C. (31)
Washington State (381)
Wisconsin (16)
271,586 Results for "adc therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
April 24, 2025
·
4 min read
Press Releases
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
May 9, 2025
·
4 min read
Press Releases
Adcentrx Therapeutics Granted Fast Track Designation for ADRX-0706 Nectin-4 ADC for the Treatment of Advanced Cervical Cancer
May 7, 2025
·
4 min read
Press Releases
Adcentrx Therapeutics to Present First Clinical Data for ADRX-0706 Nectin-4 ADC at ASCO 2025
April 23, 2025
·
4 min read
Press Releases
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025
April 28, 2025
·
6 min read
Press Releases
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
4 min read
Antibody-drug conjugate
Next-Gen ADCs Driving ‘Renaissance’ in Already Hot Oncology Drug Class
ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and toxicity challenges of current ADCs—and rapidly grow the multibillion-dollar market.
November 25, 2024
·
7 min read
·
Greg Slabodkin
Press Releases
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
March 18, 2025
·
10 min read
Press Releases
Iksuda to Present Growing ADC Pipeline at AACR
April 25, 2025
·
4 min read
Press Releases
CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR
May 7, 2025
·
10 min read
1 of 27,159
Next
